Asifa Haider

3.8k total citations · 1 hit paper
26 papers, 2.3k citations indexed

About

Asifa Haider is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Asifa Haider has authored 26 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 12 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Asifa Haider's work include Psoriasis: Treatment and Pathogenesis (7 papers), CAR-T cell therapy research (5 papers) and Dermatology and Skin Diseases (5 papers). Asifa Haider is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (7 papers), CAR-T cell therapy research (5 papers) and Dermatology and Skin Diseases (5 papers). Asifa Haider collaborates with scholars based in United States, France and Australia. Asifa Haider's co-authors include James G. Krueger, Irma Cardinale, Michelle A. Lowes, Judilyn Fuentes‐Duculan, Lisa C. Zaba, Toyoko Kikuchi, Edward P. Bowman, Inna Novitskaya, Mayte Suárez‐Fariñas and Artemis Khatcherian and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Asifa Haider

26 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells

2008 855 citations Michelle A. Lowes, Toyoko Kikuchi et al. Journal of Investigative Dermatology profile →

Peers

Countries citing papers authored by Asifa Haider

Since Specialization

Citations

This map shows the geographic impact of Asifa Haider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asifa Haider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asifa Haider more than expected).

Fields of papers citing papers by Asifa Haider

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asifa Haider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asifa Haider. The network helps show where Asifa Haider may publish in the future.

Co-authorship network of co-authors of Asifa Haider

This figure shows the co-authorship network connecting the top 25 collaborators of Asifa Haider. A scholar is included among the top collaborators of Asifa Haider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asifa Haider. Asifa Haider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and early efficacy results of phase 1 study of affinity tuned and trackable AIC100 CAR T cells in ICAM-1 positive relapsed and/or refractory advanced poorly differentiated and anaplastic thyroid cancers. 2023 ·Journal of Clinical Oncology ·Samer A. Srour, Maria E. Cabanillas, Sonal Gupta, Mark Zafereo, Yang Lü, Ramona Dadu, (unknown), Melissa M. Cushing, Scott T. Avecilla, Theresa Scognamiglio, Moonsoo M. Jin, Janusz Puc, (unknown), Karrie Du, Asifa Haider, Sebastian Mayer, Jingmei Hsu, Thomas J. Fahey, Koen van Besien	5
2	Preliminary Results from the Flu/Cy/Alemtuzumab Arm of the Phase I BALLI-01 Trial of UCART22, an Anti-CD22 Allogeneic CAR-T Cell Product, in Adult Patients with Relapsed or Refractory (R/R) CD22+ B-Cell Acute Lymphoblastic Leukemia (B-ALL) 2021 ·Blood ·Nitin Jain, Gail J. Roboz, Marina Konopleva, Hongtao Liu, Gary J. Schiller, Elias Jabbour, (unknown), Asifa Haider, (unknown), Mark G. Frattini, Carrie Brownstein, Richard A. Larson	11
3	Preliminary Results of Balli-01: A Phase I Study of UCART22 (allogeneic engineered T-cells expressing anti-CD22 Chimeric Antigen Receptor) in Adult Patients with Relapsed or Refractory (R/R) CD22+ B-Cell Acute Lymphoblastic Leukemia (B-ALL) 2020 ·Blood ·Nitin Jain, Gail J. Roboz, Marina Konopleva, Hongtao Liu, Elias Jabbour, (unknown), (unknown), Agnès Gouble, Asifa Haider, (unknown), Richard A. Larson	19
4	Apostream to isolate circulating tumor cells (CTC) from castration-resistant prostate cancer patients (CRPC) that express androgen receptor variant 7 (AR-V7) associated with resistance to AR-targeting drugs. 2016 ·Journal of Clinical Oncology ·Darren W. Davis, Asifa Haider, (unknown), Fabien Schmidlin	1
5	A Single Intradermal Injection of IFN-γ Induces an Inflammatory State in Both Non-Lesional Psoriatic and Healthy Skin 2012 ·Journal of Investigative Dermatology ·Leanne M. Johnson-Huang, Mayte Suárez‐Fariñas, Katherine C. Pierson, Judilyn Fuentes‐Duculan, Inna Cueto, Tim Lentini, Mary Sullivan‐Whalen, Patricia Gilleaudeau, James G. Krueger, Asifa Haider, Michelle A. Lowes	95
6	Personalized medicine in psoriasis: developing a genomic classifier to predict histological response to Alefacept 2010 ·BMC Dermatology ·Mayte Suárez‐Fariñas, Kejal R. Shah, Asifa Haider, James G. Krueger, Michelle A. Lowes	39
7	Supplementary Materials for Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis 2010 ·Wolfgang Hueber, Dhavalkumar D. Patel, Thaddeus P. Dryja, A. Wright, Gerard Bruin, Christian Antoni, Michael H. Gold, Patrick Durez, Paul P. Tak, (unknown), C. Stephen Foster, Rosa Y. Kim, C. Michael Samson, Naomi S. Falk, David Chu, David Callanan, Asifa Haider	139
8	Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells breakdown → 2008 ·Journal of Investigative Dermatology ·Michelle A. Lowes, Toyoko Kikuchi, Judilyn Fuentes‐Duculan, Irma Cardinale, Lisa C. Zaba, Asifa Haider, Edward P. Bowman, James G. Krueger	855
9	Human Basal Cell Carcinoma Is Associated with Foxp3+ T cells in a Th2 Dominant Microenvironment 2007 ·Journal of Investigative Dermatology ·(unknown), Emma Guttman‐Yassky, Michelle A. Lowes, Asifa Haider, Judilyn Fuentes‐Duculan, Kamruz Darabi, (unknown), Artemis Khatcherian, Irma Cardinale, Inna Novitskaya, James G. Krueger, John A. Carucci	103
10	Insights into Gene Modulation by Therapeutic TNF and IFNγ Antibodies: TNF Regulates IFNγ Production by T Cells and TNF-Regulated Genes Linked to Psoriasis Transcriptome 2007 ·Journal of Investigative Dermatology ·Asifa Haider, Jules Cohen, Fei Ji, Lisa C. Zaba, Irma Cardinale, Toyoko Kikuchi, Jürg Ott, James G. Krueger	31
11	Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis 2007 ·Journal of Allergy and Clinical Immunology ·Emma Guttman‐Yassky, Michelle A. Lowes, Judilyn Fuentes‐Duculan, (unknown), Inna Novitskaya, Irma Cardinale, Asifa Haider, Artemis Khatcherian, John A. Carucci, Richard N. Bergman, James G. Krueger	193
12	Effects of Etanercept Are Distinct from Infliximab in Modulating Proinflammatory Genes in Activated Human Leukocytes 2007 ·Journal of Investigative Dermatology Symposium Proceedings ·Asifa Haider, Irma Cardinale, (unknown), James G. Krueger	37
13	Cellular Genomic Maps Help Dissect Pathology in Human Skin Disease 2007 ·Journal of Investigative Dermatology ·Asifa Haider, Michelle A. Lowes, Mayte Suárez‐Fariñas, Lisa C. Zaba, Irma Cardinale, Miroslav Blumenberg, James G. Krueger	29
14	Bioinformatics Tools Enabling U-Statistics for Microarrays 2006 ·PubMed ·Knut M. Wittkowski, Asifa Haider, Ephraim Sehayek, Mayte Suárez‐Fariñas, Maurizio Pellegrino, (unknown), (unknown), (unknown)	3
15	Genomic Analysis Defines a Cancer-Specific Gene Expression Signature for Human Squamous Cell Carcinoma and Distinguishes Malignant Hyperproliferation from Benign Hyperplasia 2006 ·Journal of Investigative Dermatology ·Asifa Haider, Sara Peters, (unknown), Irma Cardinale, Fei Ji, Jürg Ott, Miroslav Blumenberg, A. Bowcock, James G. Krueger, John A. Carucci	149
16	Prominent Production of IL-20 by CD68+/CD11c+ Myeloid-Derived Cells in Psoriasis: Gene Regulation and Cellular Effects 2006 ·Journal of Investigative Dermatology ·Frank Wang, Edmund Lee, Michelle A. Lowes, Asifa Haider, Judilyn Fuentes‐Duculan, (unknown), Francesca Chamian, Irma Cardinale, James G. Krueger	86
17	"Harshlighting" small blemishes on microarrays 2005 ·BMC Bioinformatics ·Mayte Suárez‐Fariñas, Asifa Haider, Knut M. Wittkowski	20
18	In vitro model of “wound healing” analyzed by laser scanning cytometry: Accelerated healing of epithelial cell monolayers in the presence of hyaluronate 2003 ·Cytometry Part A ·Asifa Haider, Jerzy Grabarek, (unknown), Paulina L. Pedraza, Nicholas R. Ferreri, Endre A. Balazs, Zbigniew Darżynkiewicz	27
19	Dual Functionality of Cyclooxygenase-2 as a Regulator of Tumor Necrosis Factor–Mediated G ₁ Shortening and Nitric Oxide–Mediated Inhibition of Vascular Smooth Muscle Cell Proliferation 2003 ·Circulation ·Asifa Haider, Irene Lee, Jerzy Grabarek, Zbigniew Darżynkiewicz, Nicholas R. Ferreri	22
20	Regulation of Cyclooxygenase by the Heme-Heme Oxygenase System in Microvessel Endothelial Cells 2002 ·Journal of Pharmacology and Experimental Therapeutics ·Asifa Haider, Rafał Olszanecki, R Gryglewski, Michal L. Schwartzman, Elias A. Lianos, Attallah Kappas, Alberto Nasjletti, Nader G. Abraham	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact